JOHN HOPE FRANKLIN CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 5K

Market Cap: -

Website: http://www.duke.edu

Clinical Trials

Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal

Phase 4

Terminated

Conditions: Schizophrenia

First Posted Date: 2006-04-14

Last Posted Date: 2017-12-02

Lead Sponsor: Duke University

Target Recruit Count: 30

Registration Number: NCT00314613

Locations: 🇺🇸
John Umstead Hospital, Butner, North Carolina, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer

Phase 1

Completed

Conditions: Hematologic Neoplasms

First Posted Date: 2006-04-10

Last Posted Date: 2012-04-03

Lead Sponsor: Duke University

Target Recruit Count: 34

Registration Number: NCT00312429

Locations: 🇺🇸
Duke University, Durham, North Carolina, United States

Weight Management and Coping Skills Training For Patients With Knee Osteoarthritis

Not Applicable

Completed

Conditions: Osteoarthritis

Interventions: Behavioral: Lifestyle Behavioral Weight Management Program
Other: Standard Care
Behavioral: Pain-Coping Skills Training

First Posted Date: 2006-03-22

Last Posted Date: 2018-10-25

Lead Sponsor: Duke University

Target Recruit Count: 412

Registration Number: NCT00305890

Locations: 🇺🇸
Duke University Morreene Rd. Clinic, Durham, North Carolina, United States

Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are Overweight

Phase 2

Completed

Conditions: Colorectal Cancer
Breast Cancer
Prostate Cancer

Interventions: Behavioral: behavioral dietary and exercise intervention

First Posted Date: 2006-03-17

Last Posted Date: 2017-02-23

Lead Sponsor: Duke University

Target Recruit Count: 641

Registration Number: NCT00303875

Locations: 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
🇺🇸
Veterans Affairs Medical Center - Durham, Durham, North Carolina, United States

Exercise to Treat Depression in Individuals With Coronary Heart Disease

Phase 3

Completed

Conditions: Depression
Heart Diseases

Interventions: Behavioral: Supervised Aerobic Exercise
Drug: Placebo Pill.
Drug: Sertraline

First Posted Date: 2006-03-13

Last Posted Date: 2015-06-29

Lead Sponsor: Duke University

Target Recruit Count: 101

Registration Number: NCT00302068

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma

Phase 2

Completed

Conditions: Brain Tumors
Osteoporosis
Central Nervous System(CNS)Malignancies

Interventions: Drug: IV Zometa

First Posted Date: 2006-03-13

Last Posted Date: 2013-02-18

Lead Sponsor: Duke University

Target Recruit Count: 60

Registration Number: NCT00301873

Locations: 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States

Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder

Phase 2

Terminated

Conditions: Obsessive-Compulsive Disorder

Interventions: Drug: Placebo
Drug: Sertraline
Drug: Levetiracetam

First Posted Date: 2006-03-07

Last Posted Date: 2013-04-11

Lead Sponsor: Duke University

Target Recruit Count: 12

Registration Number: NCT00299611

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen

Phase 1

Completed

Conditions: Chronic Hepatitis C
Organ Transplantation
Immunosuppression

First Posted Date: 2006-02-06

Last Posted Date: 2014-09-22

Lead Sponsor: Duke University

Target Recruit Count: 40

Registration Number: NCT00286871

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Rituximab in the Treatment of Patients With Bullous Pemphigoid

Phase 1

Completed

Conditions: Bullous Pemphigoid

Interventions: Drug: Rituximab

First Posted Date: 2006-02-03

Last Posted Date: 2013-04-11

Lead Sponsor: Duke University

Target Recruit Count: 8

Registration Number: NCT00286325

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Phase 1

Completed

Conditions: Esophageal Cancer

First Posted Date: 2006-01-25

Last Posted Date: 2013-03-21

Lead Sponsor: Duke University

Target Recruit Count: 13

Registration Number: NCT00281788

Locations: 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy